Cannabis Products was IM Cannabis’s largest revenue line in fiscal 2023, bringing in $44.25M of $48.80M (91%).
| Products and services [axis] | FY 2022 | FY 2023 |
|---|---|---|
| Cannabis Products | $48.38M | $44.25M |
| Other Cannabis | $5.95M | $4.56M |
| Total | $54.34M | $48.80M |
IM Cannabis brought in $48.80M from its two revenue lines in fiscal 2023, the year ended December 31, 2023. That was down 10.2% from $54.34M in fiscal 2022. Cannabis Products was the largest at $44.25M (90.7%), ahead of Other Cannabis at $4.56M (9.3%).
Compared with fiscal 2022, Cannabis Products fell 8.6% to $44.25M and Other Cannabis fell 23.4% to $4.56M.
IM Cannabis (IMCC) reports its revenue by products and services [axis]. In fiscal 2023, Cannabis Products was its largest revenue line, bringing in $44.25M (90.7% of the total), followed by Other Cannabis at $4.56M (9.3%).
Cannabis Products was IM Cannabis' largest revenue line in fiscal 2023, bringing in $44.25M, or 90.7% of the $48.80M total across its two revenue lines.
Every figure comes from IM Cannabis' annual financial filings, as reported. Each line keeps the name IM Cannabis gives it, and years follow its fiscal calendar.
IM Cannabis' revenue by products and services [axis] goes back to fiscal 2022, with figures through fiscal 2023. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.